Free webinar 29 July | Fragile X syndrome | Clinical trials in Australia

July 28th, 2021

On 29 July we hosted a practical discussion and Q&A on how clinical trials contribute to the development of treatments for Fragile X syndrome, and an overview of upcoming clinical trials in Australia.

The speakers are exceptionally well versed in Fragile X syndrome and the conduct of clinical trials, and are well known to many families.

Dr Honey Heussler,  Queensland Children’s Hospital
Michael Duhig, Clinical Research Manager at Queensland Children’s Hospital
Prof David Amor, Royal Children’s Hospital, Melbourne
Dr Natalie Silove, Westmead Children’s Hospital, Sydney for Q&A
Prof Ted Brown
, President, FXAA

The recording of the webinar is now online:

The webinar is hosted by Fragile X Association of Australia, and supported by Zynerba Pharmaceuticals.



World Fragile X Day!

22 July | Celebrating everyone living with Fragile X and acknowledging the work being done to ensure early diagnosis and access to future treatments. Your support will help enable us to provide support to the Fragile X community around Australia through our HelpLine, specialist counselling, peer connections, educational webinars, referrals and advocacy. We are grateful for your lead.

Make a donation to Fragile X Association
Fragile X Logo